Praveen P. Tipirneni Morphic Holding, Inc. (MORF) insider trading activity

Praveen P. Tipirneni is President and CEO of Morphic Holding, Inc.. Currently has a direct ownership of 0 shares of MORF, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2021, when has been sold 1,653 shares (Common Stock) at a price of $4.32 per share, resulting in proceeds of $7,141. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Praveen P. Tipirneni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2021	BUY Exercise of conversion of derivative security	$7,141 $4.32 p/Share	1,653 Added 23.22%	5,466 Common Stock
Jan 04 2021	SELL Open market or private sale	$77,709 $33.11 p/Share	2,347 Reduced 38.1%	3,813 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$10,139 $4.32 p/Share	2,347 Added 27.59%	6,160 Common Stock
Dec 22 2020	SELL Open market or private sale	$79,493 $35.05 p/Share	2,268 Reduced 37.3%	3,813 Common Stock
Dec 22 2020	BUY Exercise of conversion of derivative security	$9,798 $4.32 p/Share	2,268 Added 27.16%	6,081 Common Stock
Dec 21 2020	SELL Open market or private sale	$7,002 $35.01 p/Share	200 Reduced 4.98%	3,813 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$864 $4.32 p/Share	200 Added 4.75%	4,013 Common Stock
Dec 16 2020	SELL Open market or private sale	$35,200 $35.2 p/Share	1,000 Reduced 20.78%	3,813 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	$4,320 $4.32 p/Share	1,000 Added 17.2%	4,813 Common Stock
Dec 10 2020	SELL Open market or private sale	$21,294 $35.49 p/Share	600 Reduced 13.6%	3,813 Common Stock
Dec 10 2020	BUY Exercise of conversion of derivative security	$2,592 $4.32 p/Share	600 Added 11.97%	4,413 Common Stock
Dec 01 2020	SELL Open market or private sale	$124,960 $31.24 p/Share	4,000 Reduced 51.2%	3,813 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$17,280 $4.32 p/Share	4,000 Added 33.86%	7,813 Common Stock
Nov 18 2020	SELL Open market or private sale	$9,810 $30.0 p/Share	327 Reduced 8.58%	3,486 Common Stock
Nov 18 2020	BUY Exercise of conversion of derivative security	$1,413 $4.32 p/Share	327 Added 7.9%	3,813 Common Stock
Nov 17 2020	SELL Open market or private sale	$81,661 $30.1 p/Share	2,713 Reduced 43.77%	3,486 Common Stock
Nov 17 2020	BUY Exercise of conversion of derivative security	$11,720 $4.32 p/Share	2,713 Added 30.44%	6,199 Common Stock
Nov 16 2020	SELL Open market or private sale	$15,015 $30.03 p/Share	500 Reduced 13.21%	3,286 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$864 $4.32 p/Share	200 Added 5.43%	3,486 Common Stock
Nov 13 2020	BUY Exercise of conversion of derivative security	$1,296 $4.32 p/Share	300 Added 7.72%	3,586 Common Stock
Nov 12 2020	SELL Open market or private sale	$13,800 $30.0 p/Share	460 Reduced 12.28%	3,286 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$1,987 $4.32 p/Share	460 Added 10.94%	3,746 Common Stock
Nov 09 2020	SELL Open market or private sale	$69,246 $27.61 p/Share	2,508 Reduced 43.29%	3,286 Common Stock
Nov 09 2020	BUY Exercise of conversion of derivative security	$10,835 $4.32 p/Share	2,508 Added 30.21%	5,794 Common Stock
Nov 06 2020	SELL Open market or private sale	$114,153 $26.14 p/Share	4,367 Reduced 57.06%	3,286 Common Stock

Also insider at

AVRO

AVROBIO, Inc. Healthcare

PPT